FMS vs VLXC
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FMS is a Hold and VLXC is a Hold.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
FMS’s FA Score shows that 1 FA rating(s) are green whileVLXC’s FA Score has 0 green FA rating(s).
- FMS’s FA Score: 1 green, 4 red.
- VLXC’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
FMS’s TA Score shows that 2 TA indicator(s) are bullish.
- FMS’s TA Score: 2 bullish, 3 bearish.
Price Growth
FMS (@Medical/Nursing Services) experienced а +1.67% price change this week, while VLXC (@Medical/Nursing Services) price change was -6.61% for the same time period.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +2.56%. For the same industry, the average monthly price growth was +5.84%, and the average quarterly price growth was -8.46%.
Reported Earning Dates
FMS is expected to report earnings on May 06, 2025.
Industries' Descriptions
@Medical/Nursing Services (+2.56% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
| FMS | VLXC | FMS / VLXC | |
| Capitalization | 11.2B | 13.5M | 82,963% |
| EBITDA | 3.21B | N/A | - |
| Gain YTD | 2.341 | 0.358 | 654% |
| P/E Ratio | 20.80 | N/A | - |
| Revenue | 19.5B | N/A | - |
| Total Cash | 1.54B | 19.9K | 7,738,693% |
| Total Debt | 12.1B | 1.57M | 773,163% |
FMS | VLXC | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 7 | 78 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 13 Undervalued | 96 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 84 | 100 | |
PRICE GROWTH RATING 1..100 | 46 | 93 | |
P/E GROWTH RATING 1..100 | 81 | 100 | |
SEASONALITY SCORE 1..100 | 50 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
FMS's Valuation (13) in the Medical Or Nursing Services industry is significantly better than the same rating for VLXC (96) in the null industry. This means that FMS’s stock grew significantly faster than VLXC’s over the last 12 months.
FMS's Profit vs Risk Rating (100) in the Medical Or Nursing Services industry is in the same range as VLXC (100) in the null industry. This means that FMS’s stock grew similarly to VLXC’s over the last 12 months.
FMS's SMR Rating (84) in the Medical Or Nursing Services industry is in the same range as VLXC (100) in the null industry. This means that FMS’s stock grew similarly to VLXC’s over the last 12 months.
FMS's Price Growth Rating (46) in the Medical Or Nursing Services industry is somewhat better than the same rating for VLXC (93) in the null industry. This means that FMS’s stock grew somewhat faster than VLXC’s over the last 12 months.
FMS's P/E Growth Rating (81) in the Medical Or Nursing Services industry is in the same range as VLXC (100) in the null industry. This means that FMS’s stock grew similarly to VLXC’s over the last 12 months.
| FMS | |
|---|---|
| RSI ODDS (%) | N/A |
| Stochastic ODDS (%) | 10 days ago 52% |
| Momentum ODDS (%) | 10 days ago 62% |
| MACD ODDS (%) | N/A |
| TrendWeek ODDS (%) | 10 days ago 60% |
| TrendMonth ODDS (%) | 10 days ago 64% |
| Advances ODDS (%) | 18 days ago 62% |
| Declines ODDS (%) | 16 days ago 60% |
| BollingerBands ODDS (%) | N/A |
| Aroon ODDS (%) | 10 days ago 65% |
FMS and
Correlation & Price change
A.I.dvisor indicates that over the last year, FMS has been loosely correlated with DVA. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if FMS jumps, then DVA could also see price increases.
| Ticker / NAME | Correlation To FMS | 1D Price Change % | ||
|---|---|---|---|---|
| FMS | 100% | +0.35% | ||
| DVA - FMS | 49% Loosely correlated | -0.89% | ||
| UHS - FMS | 31% Poorly correlated | -0.93% | ||
| USPH - FMS | 28% Poorly correlated | +0.22% | ||
| HCA - FMS | 27% Poorly correlated | +0.33% | ||
| HCSG - FMS | 27% Poorly correlated | -3.30% | ||
More | ||||
VLXC and
Correlation & Price change
A.I.dvisor tells us that VLXC and BUGDF have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that VLXC and BUGDF's prices will move in lockstep.
| Ticker / NAME | Correlation To VLXC | 1D Price Change % | ||
|---|---|---|---|---|
| VLXC | 100% | N/A | ||
| BUGDF - VLXC | 23% Poorly correlated | N/A | ||
| FMS - VLXC | 22% Poorly correlated | +0.35% | ||
| RKAGY - VLXC | 15% Poorly correlated | N/A | ||
| RHCGF - VLXC | 2% Poorly correlated | -6.17% | ||
| CMPS - VLXC | 2% Poorly correlated | +2.47% | ||
More | ||||